The cost of new anti-cancer drugs increased more than five-fold from 2006 to 2015, but a new analysis suggests that cancer patients and insurers may be getting less for their money.
Pharmaceutical Care
Management Association
505 9th Street NW, 10th Floor, Washington, DC 20004
© 2025 PCMA. All Rights Reserved.